Should I buy or sell Gpt Healthcare?

The average broker rating on Gpt Healthcare is Hold. The breakup of analyst rating is given below - 0.00 analysts have given a strong sell rating 0.00 analysts have given a sell rating 1 analysts have given a hold rating 0.00 analysts have given a buy rating 0.00 analysts have given a strong buy rating

Is Gpt Healthcare a good stock to invest in?

Gpt Healthcare can be analyzed on the following key metrics - TTM P/E: 24.17 Sector P/E: 22.44 Dividend Yield: 1.72% D/E ratio: -

Gpt Healthcare Share Price

Sector: Healthcare Facilities

Powered by

147.10 +1.30 (0.89%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 145.65

Today’s High 147.80

52 Week Low 126.15

52 Week High 206.50

Key Metrics

Market Cap (In Cr) 1204.57
Beta -
Div. Yield (%) 1.72
P/B 4.82
TTM P/E 24.17
Peg Ratio 3.87
Sector P/E 22.44
D/E 0
Open Price 146.15
Prev Close 145.8

View All Metrics

Gpt Healthcare Analysis

Price Analysis

1 Week

0.54%
3 Months

5.11%
6 Month

-20.66%
YTD

-20.78%
1 Year

-3.05%

Risk Meter

34% Low risk
34% Moderate risk
34% Balanced Risk
34% High risk
34% Extreme risk

Recos

Strong Sell
Sell
Hold
Buy
Strong Buy

Analysts' Views

Ratings
Current
1 W Ago
1 M Ago
3 M Ago

Strong Buy
0.00
0.00
1
1

Buy
0.00
0.00
0.00
0.00

Hold
1
1
0.00
0.00

Sell
0.00
0.00
0.00
0.00

Strong Sell
0.00
0.00
0.00
0.00

Total
1
1
1
1

Gpt Healthcare News

Julián, a software engineer at Microsoft in Madrid, realised something powerful: technology, especially AI, could help stop other families from going through the same nightmare.
(Microsoft blog)

Premium

DxGPT: How Microsoft’s AI is helping families find diagnoses for rare diseases

2 min read . 28 Apr 2025

Businessman using laptop for analyzing data stock market, forex trading graph, stock exchange trading online, financial investment concept. All on laptop screen are design up.

Premium

Hospital stocks rise as govt plans daycare cancer centers in district hospitals

2 min read . 01 Feb 2025

Multibagger IPOs: 11 companies soar over 100% from issue price in Samvat 2080 (iStock)

Premium

Multibagger IPOs: 12 companies soar over 100% from issue price in Samvat 2080

4 min read . 29 Oct 2024

Premium

Stocks to Watch: UltraTech Cement, AU Small Finance Bank, Vedanta, and more

3 min read . 27 Aug 2024

View More News

Gpt Healthcare Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
407.09

Selling/ General/ Admin Expenses Total
73.02

Depreciation/ Amortization
19.03

Other Operating Expenses Total
171.93

Total Operating Expense
342.77

Operating Income
64.32

Net Income Before Taxes
69.35

Net Income
49.92

Diluted Normalized EPS
6.08

Period
2024

Total Revenue
400.19

Selling/ General/ Admin Expenses Total
97.87

Depreciation/ Amortization
17.98

Other Operating Expenses Total
130.41

Total Operating Expense
328.84

Operating Income
71.35

Net Income Before Taxes
68.04

Net Income
47.77

Diluted Normalized EPS
5.95

Period
2023

Total Revenue
361.04

Selling/ General/ Admin Expenses Total
66.19

Depreciation/ Amortization
14.91

Other Operating Expenses Total
143.58

Total Operating Expense
301.23

Operating Income
59.8

Net Income Before Taxes
55.97

Net Income
39.01

Diluted Normalized EPS
4.77

Period
2022

Total Revenue
337.42

Selling/ General/ Admin Expenses Total
56.7

Depreciation/ Amortization
13.59

Other Operating Expenses Total
118.97

Total Operating Expense
276.65

Operating Income
60.77

Net Income Before Taxes
54.08

Net Income
41.66

Diluted Normalized EPS
5.09

Period
2021

Total Revenue
242.75

Selling/ General/ Admin Expenses Total
43.27

Depreciation/ Amortization
12.47

Other Operating Expenses Total
92.98

Total Operating Expense
205.99

Operating Income
36.76

Net Income Before Taxes
28.88

Net Income
21.09

Diluted Normalized EPS
2.51

Period
2020

Total Revenue
211.84

Selling/ General/ Admin Expenses Total
45.99

Depreciation/ Amortization
11.08

Other Operating Expenses Total
91.42

Total Operating Expense
186.9

Operating Income
24.95

Net Income Before Taxes
14.84

Net Income
10.96

Diluted Normalized EPS
1.34

Period
2019

Total Revenue
171.87

Selling/ General/ Admin Expenses Total
34.2

Depreciation/ Amortization
9

Other Operating Expenses Total
69.78

Total Operating Expense
143.66

Operating Income
28.21

Net Income Before Taxes
20.38

Net Income
14.95

Diluted Normalized EPS
1.82

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Gpt Healthcare Technical

Moving Average SMA

5 Day144.9
10 Day147.68
20 Day149.58

50 Day154.35
100 Day151.45
300 Day164.71

Gpt Healthcare Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Dr. Agarwal's Eye Hospital
4312
-4.4
-0.1
7300
3114.3
2017.95

Shalby
181.8
-0.9
-0.49
325
177.2
1956.68

Gpt Healthcare
147.1
1.3
0.89
206.5
126.15
1204.57

Kerala Ayurveda
585
47.4
8.82
559
250
703.9

Forbes And Company
436
1.8
0.41
787.95
264.35
558.84

Gpt Healthcare Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

23-May-25
Audited Results & Final Dividend

11-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results & Interim Dividend

13-Aug-24
Quarterly Results

21-May-24
Audited Results & Final Dividend

19-Mar-24
Quarterly Results & Interim Dividend

Meeting Date
Announced on
Purpose

05-Aug-25
23-May-25
AGM

25-Jul-24
21-May-24
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

23-May-25
29-Jul-25
29-Jul-25
1.5

14-Nov-24
28-Nov-24
28-Nov-24
1

21-May-24
-
18-Jul-24
1.5

19-Mar-24
02-Apr-24
02-Apr-24
1

View All

Company Profile

ABOUT Gpt Healthcare

Industry Healthcare Facilities
ISIN INE486R01017
BSE Code 544131
NSE Code GPTHEALTH

GPT Healthcare Limited is an India-based company. The Company’s principal activities include the operation of multidisciplinary private hospitals and pharmacies. It has four multispecialty hospitals, two in Kolkata, Salt Lake, one in Agartala and one hospital in Howrah, West Bengal, and has one nursing institute in Agartala, under the brand name ILS Hospitals. ILS Hospitals, Agartala, has approximately 205 bedded multispecialty hospital with a 50 Seat B.Sc. Nursing College. ILS Hospitals, Agartala has operating theaters, a catheterization laboratory and other diagnostic and therapeutic equipment. The ILS Hospitals Dumdum has approximately 155 bedded multispecialty hospital with operation theaters, a catheterization laboratory and other diagnostic and therapeutic equipment. ILS Hospitals Howrah is a multi-specialty hospital which is equipped with over 116 beds. ILS Hospitals Salt Lake is a multispecialty hospital with approximately 85 beds and three operation theaters.

MANAGEMENT

Pramod Sureka Whole-Time Director

GPT HEALTHCARE SUMMARY

Gpt Healthcare is trading 0.89% upper at Rs 147.10 as compared to its last closing price. Gpt Healthcare has been trading in the price range of 147.80 & 145.65. Gpt Healthcare has given -20.78% in this year & 0.54% in the last 5 days.

Gpt Healthcare has TTM P/E ratio 24.17 as compared to the sector P/E of 22.44. There are 1 analysts who have initiated coverage on Gpt Healthcare. There are 0.00 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

The company posted a net profit of 12.89 Crores in its last quarter.

Listed peers of Gpt Healthcare include Dr. Agarwal's Eye Hospital (-0.1%), Shalby (-0.49%), Gpt Healthcare (0.89%) etc.

Gpt Healthcare has a 65.57% promoter holding & 34.43% public holding.

FAQs about Gpt Healthcare

Gpt Healthcare is trading at 147.10 as on 27 Jun, 2025 3:29:45 PM. This is 0.89% upper as compared to its previous closing price of 145.8

The market capitalization of Gpt Healthcare is 1204.57 Cr as on 27 Jun, 2025 3:29:45 PM.

The average broker rating on Gpt Healthcare is Hold. The breakup of analyst rating is given below -

0.00 analysts have given a strong sell rating
0.00 analysts have given a sell rating
1 analysts have given a hold rating
0.00 analysts have given a buy rating
0.00 analysts have given a strong buy rating

The 52 wk high for Gpt Healthcare is 206.50 whereas the 52 wk low is 126.15

Gpt Healthcare can be analyzed on the following key metrics -

TTM P/E: 24.17
Sector P/E: 22.44
Dividend Yield: 1.72%
D/E ratio: -

Gpt Healthcare reported a net profit of 49.92 Cr in 2025.

Gpt Healthcare Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Gpt Healthcare Share Price

Price Range

Price Range

Key Metrics

Gpt Healthcare Analysis

Gpt Healthcare News

DxGPT: How Microsoft’s AI is helping families find diagnoses for rare diseases

Hospital stocks rise as govt plans daycare cancer centers in district hospitals

Multibagger IPOs: 12 companies soar over 100% from issue price in Samvat 2080

Stocks to Watch: UltraTech Cement, AU Small Finance Bank, Vedanta, and more

Gpt Healthcare Financials

Forecast

Forecast

Forecast

Gpt Healthcare Technical

Gpt Healthcare Peers

Gpt Healthcare Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Gpt Healthcare

MANAGEMENT

GPT HEALTHCARE SUMMARY

FAQs about Gpt Healthcare

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue